dronedarone has been researched along with Auricular Flutter in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (24.39) | 29.6817 |
2010's | 18 (43.90) | 24.3611 |
2020's | 13 (31.71) | 2.80 |
Authors | Studies |
---|---|
Ma, CS; Sun, YH; Wu, SL | 1 |
Calkins, H; Hohnloser, SH; Lip, GYH; Ludwigs, U; Nam, GB; Oldgren, J; Stewart, J; Ueng, KC; Vamos, M; Wieloch, M; Zhu, J | 1 |
Atar, D; Crijns, HJGM; Kowey, P; Ludwigs, U; Pak, HN; Reiffel, J; Stewart, J; Thind, M; Wieloch, M; Zareba, W; Zhu, J | 1 |
Kowey, PR; McKindley, DS; Naccarelli, GV; Reiffel, JA; Stewart, J; Thind, M | 1 |
Albuquerque, APA; Anker, SD; Braceras, R; Butler, J; Camm, AJ; Crijns, HJGM; Hohnloser, SH; Piccini, JP; Stewart, J; Vaduganathan, M; Wieloch, M | 1 |
Bai, R; Lin, JL; Ma, C; Nam, GB; Stewart, J; Sun, Y; Wieloch, M; Zhu, J | 1 |
Bigot, G; Blomström-Lundqvist, C; Hohnloser, SH; McKindley, DS; Naccarelli, GV; Wieloch, M | 1 |
Calkins, H; Corp Dit Genti, V; Hohnloser, SH; Koren, A; Kowey, PR; Torp-Pedersen, CT; Vamos, M; Wieloch, M | 1 |
Corp Dit Genti, V; Crijns, HJ; Koren, A; Kowey, PR; Naccarelli, GV; Reiffel, JA; Thind, M; Wieloch, M | 1 |
Bohn, RL; Bozzi, S; Goehring, EL; Jones, JK; Naccarelli, GV; Pezzullo, J; Sicignano, N; Tamayo, RCSG; Tave, AK | 1 |
Choi, EK; Kim, JA; Kim, JH; Kwon, TY; Lee, SR; Lee, YE; Oh, S | 1 |
Boiron, R; Gandhi, S; Juhaeri, J; Kechemir, H; Lin, S; Wieloch, M; Wu, C | 1 |
Bhattacharyya, N; Bogard, A; Curtis, AB; Hohnloser, SH; Malik, A; Stewart, J; Zeitler, EP | 1 |
Bollmann, A; Hindricks, G; Husser, D; John, S; Kornej, J; Löbe, S; Salmáš, J | 1 |
Goldberger, JJ; Teme, T | 1 |
Jhaveri, M; Kim, MH; Koren, A; Lin, J | 1 |
Kowey, PR; Naccarelli, GV | 1 |
Aliot, EM; Capucci, A; Connolly, S; Crijns, HJ; Guerra, F; Hohnloser, SH; Kowey, PR; Radzik, D; Roy, D | 1 |
Clark, AL; Cleland, JG; Coletta, AP; Cullington, D | 1 |
Preobrazhenskiĭ, DV | 1 |
Zimetbaum, PJ | 1 |
Kowey, PR; Patel, C; Yan, GX | 1 |
Connolly, SJ; Crijns, HJ; Gaudin, C; Hohnloser, SH; Page, RL; Torp-Pedersen, C; van Eickels, M | 2 |
Christiansen, CB; Køber, L; Torp-Pedersen, C | 1 |
Lewalter, T | 1 |
Cooper, JA | 1 |
Duray, GZ; Hohnloser, SH; Schmitt, J | 1 |
Johnston, SS; Lin, J; Naccarelli, GV; Patel, PP; Schulman, KL | 1 |
Banchs, J; Gonzalez, M; Naccarelli, G; Penny-Peterson, E; Samii, S; Wolbrette, D | 1 |
Cohenour, FV; Freeman, MK; Hughes, PJ; Price, EM | 1 |
Fox, D; Maund, E; McKenna, C; Palmer, S; Pepper, C; Sarowar, M; Stevenson, M; Woolacott, N | 1 |
Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL | 1 |
Naccarelli, GV | 1 |
Dai, WS; Gao, S; Juhaeri, J; Koren, AT; Schiappacasse, HA | 1 |
Afzal, R; Alings, M; Amerena, J; Atar, D; Avezum, Á; Baret-Cormel, L; Blomström, P; Borggrefe, M; Budaj, A; Camm, AJ; Chen, SA; Ching, CK; Chrolavicius, S; Commerford, P; Connolly, SJ; Dans, A; Davy, JM; Delacrétaz, E; Di Pasquale, G; Diaz, R; Dorian, P; Flaker, G; Golitsyn, S; Gonzalez-Hermosillo, A; Granger, CB; Halperin, JL; Heidbüchel, H; Hohnloser, SH; Joyner, C; Kautzner, J; Kim, JS; Lanas, F; Lewis, BS; Merino, JL; Morillo, C; Murin, J; Narasimhan, C; Paolasso, E; Parkhomenko, A; Peters, NS; Sim, KH; Staiger, C; Stiles, MK; Tanomsup, S; Toivonen, L; Tomcsányi, J; Torp-Pedersen, C; Tse, HF; Vardas, P; Vinereanu, D; Weinling, E; Xavier, D; Yusuf, S; Zhu, J; Zhu, JR | 1 |
Karle, CA; Kathofer, S; Thomas, D | 1 |
Zareba, KM | 1 |
Dale, KM; White, CM | 1 |
Aliot, EM; Capucci, A; Connolly, SJ; Crijns, HJ; Hohnloser, SH; Kowey, PR; Radzik, D; Roy, D; Singh, BN | 1 |
Ezekowitz, MD | 1 |
9 review(s) available for dronedarone and Auricular Flutter
Article | Year |
---|---|
The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Half-Life; Heart Failure; Hospitalization; Humans; Randomized Controlled Trials as Topic; Risk; Secondary Prevention | 2014 |
Dronedarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Humans; Ion Channels; Kaplan-Meier Estimate | 2009 |
Efficacy and safety of dronedarone: a review of randomized trials.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Heart Failure; Heart Rate; Humans; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome | 2010 |
Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Contraindications; Dronedarone; Drug Approval; Humans; Product Surveillance, Postmarketing; Stroke Volume | 2010 |
Dronedarone: an alternative to amiodarone?
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Dronedarone; Drug Interactions; Humans | 2010 |
Dronedarone for the treatment of atrial fibrillation and atrial flutter.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Dronedarone; Humans; Middle Aged; Randomized Controlled Trials as Topic | 2010 |
A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Dronedarone; Heart Failure; Humans; Risk Factors; Secondary Prevention | 2010 |
The novel antiarrhythmic drug dronedarone: comparison with amiodarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Humans; Ion Channels | 2005 |
Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Biological Availability; Clinical Trials as Topic; Dronedarone; Drug Interactions; Half-Life; Humans | 2007 |
11 trial(s) available for dronedarone and Auricular Flutter
Article | Year |
---|---|
Dronedarone vs. placebo in patients with atrial fibrillation or atrial flutter across a range of renal function: a post hoc analysis of the ATHENA trial.
Topics: Amiodarone; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Humans; Kidney; Renal Insufficiency, Chronic | 2022 |
Efficacy and safety of dronedarone versus placebo in patients with atrial fibrillation stratified according to renal function: Post hoc analyses of the EURIDIS-ADONIS trials.
Topics: Adonis; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Humans; Kidney; Treatment Outcome | 2022 |
Effect of Dronedarone in the Treatment of Atrial Fibrillation in the Asian Population: Post Hoc Analysis of the ATHENA Trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Humans; Treatment Outcome | 2022 |
Effect of dronedarone vs. placebo on atrial fibrillation progression: a post hoc analysis from ATHENA trial.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Hospitalization; Humans | 2023 |
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Catheter Ablation; Double-Blind Method; Dronedarone; Female; Heart Rate; Hospitalization; Humans; Male; Middle Aged; Recurrence; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2020 |
Efficacy and safety of dronedarone across age and sex subgroups: a post hoc analysis of the ATHENA study among patients with non-permanent atrial fibrillation/flutter.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Female; Humans; Infant, Newborn; Male | 2022 |
[Efficacy of dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. Results of the EURIDIS and ADONIS].
Topics: Adult; Amiodarone; Atrial Fibrillation; Atrial Flutter; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Time Factors; Treatment Outcome | 2008 |
Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cause of Death; Combined Modality Therapy; Double-Blind Method; Dronedarone; Electric Countershock; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Risk; Secondary Prevention; Signal Processing, Computer-Assisted; Stroke; Utilization Review | 2011 |
Post-ATHENA and beyond.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Heart Failure; Heart Ventricles; Hospitalization; Humans; Risk Assessment; Secondary Prevention; Treatment Outcome | 2011 |
Dronedarone in high-risk permanent atrial fibrillation.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Chronic Disease; Digoxin; Double-Blind Method; Dronedarone; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Risk Factors; Stroke | 2011 |
Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Electrocardiography; Female; Heart Rate; Hospitalization; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Secondary Prevention; Time Factors | 2007 |
21 other study(ies) available for dronedarone and Auricular Flutter
Article | Year |
---|---|
[The Chinese expert recommendations on the clinical use of dronedarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; China; Dronedarone; Humans | 2021 |
Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies.
Topics: Adonis; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Female; Humans; Pharmaceutical Preparations | 2022 |
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Atrial Flutter; Dronedarone; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2022 |
Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials, Phase III as Topic; Dronedarone; Electric Countershock; Europe; Female; Heart Rate; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Retreatment; Risk Assessment; Risk Factors; Sulfonamides; Time Factors; Treatment Outcome; United States | 2020 |
Outcomes Associated with Dronedarone Use in Patients with Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Cohort Studies; Dronedarone; Epidemiologic Studies; Female; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; Risk Assessment; Treatment Outcome | 2020 |
Comparative clinical outcomes of dronedarone and sotalol in Asian patients with atrial fibrillation: a nationwide cohort study.
Topics: Aged; Anti-Arrhythmia Agents; Asian People; Atrial Fibrillation; Atrial Flutter; Cause of Death; Dronedarone; Female; Hospitalization; Humans; Male; Middle Aged; Patients; Retrospective Studies; Sotalol | 2020 |
Evaluating the Risk of Digitalis Intoxication Associated With Concomitant Use of Dronedarone and Digoxin Using Real-World Data.
Topics: Adult; Atrial Fibrillation; Atrial Flutter; Digitalis; Digoxin; Dronedarone; Humans | 2021 |
Usefulness of dronedarone in patients with atrial arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Female; Follow-Up Studies; Humans; Male; Retrospective Studies; Secondary Prevention; Treatment Outcome | 2013 |
Efficacy and tolerability of dronedarone for patients with atrial fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Catheter Ablation; Dronedarone; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Time Factors; Treatment Outcome | 2013 |
Impact of dronedarone treatment on healthcare resource utilization in patients with atrial fibrillation/flutter.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ambulatory Care; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cohort Studies; Dronedarone; Emergency Service, Hospital; Female; Health Resources; Health Services; Hospitalization; Humans; Male; Middle Aged; Retrospective Studies; United States; Young Adult | 2014 |
Efficacy and safety of dronedarone in patients previously treated with other antiarrhythmic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Female; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Sotalol | 2014 |
Clinical trials update from Heart Rhythm 2008 and Heart Failure 2008: ATHENA, URGENT, INH study, HEART and CK-1827452.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiotonic Agents; Clinical Trials as Topic; Dronedarone; Heart Failure; Humans | 2008 |
Dronedarone for atrial fibrillation--an odyssey.
Topics: Advisory Committees; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Clinical Trials as Topic; Dronedarone; Drug Approval; Humans; Molecular Structure; Stroke Volume; United States; United States Food and Drug Administration | 2009 |
Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Double-Blind Method; Dronedarone; Female; Humans; International Normalized Ratio; Male; Middle Aged; Multivariate Analysis; Placebos; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2009 |
Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Bias; Dronedarone; Electrocardiography; Humans; Meta-Analysis as Topic; Odds Ratio; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2010 |
Dronedarone is superior to placebo the case for optimism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Bias; Dronedarone; Electrocardiography; Humans; Odds Ratio; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Dronedarone therapy in atrial fibrillation: a summary of recent controlled trials.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Cardiovascular Diseases; Clinical Trials as Topic; Dronedarone; Humans | 2010 |
Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Controlled Clinical Trials as Topic; Cost Savings; Databases as Topic; Dronedarone; Drug Costs; Female; Hospital Costs; Hospital Mortality; Hospitalization; Humans; Inpatients; Male; Medicare Part B; Models, Economic; Retrospective Studies; Time Factors; Treatment Outcome; United States | 2010 |
Evaluation of dronedarone use in the US patient population between 2009 and 2010: a descriptive study using a claims database.
Topics: Adolescent; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Contraindications; Databases, Factual; Dronedarone; Drug Interactions; Drug Prescriptions; Drug Utilization Review; Female; Humans; Insurance Claim Review; Male; Middle Aged; United States; Young Adult | 2011 |
Dronedarone: a new antiarrhythmic agent.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Biological Availability; Clinical Trials as Topic; Dronedarone; Humans; Metabolic Clearance Rate; Treatment Outcome | 2006 |
Maintaining sinus rhythm--making treatment better than the disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Dronedarone; Heart Failure; Humans; Secondary Prevention | 2007 |